The best medicine for acid reflux depends on how often symptoms occur: for infrequent heartburn (fewer than two days a week), an antacid such as calcium carbonate works within 5 minutes and costs under USD 10; for frequent symptoms (two or more days a week), a proton pump inhibitor (PPI) such as omeprazole taken 30 to 60 minutes before breakfast is the most effective first-line choice, healing esophagitis in roughly 80 to 90 percent of cases over 8 weeks; for nighttime symptoms, an H2 blocker such as famotidine offers 6 to 10 hours of acid suppression with faster tolerance than most patients expect. Persistent symptoms beyond 8 weeks of PPI therapy warrant medical evaluation, not a stronger over-the-counter product.
How Acid Reflux Medicine Actually Works: Three Targets, Three Mechanisms
Acid reflux medicine works by interrupting the stomach's acid-production machinery at one of three points, and understanding which point each drug class hits explains every difference in speed, duration, and side effects between them.
The proton pump is the final common pathway. Parietal cells in the stomach lining secrete acid through an enzyme called H+/K+ ATPase, the proton pump. PPIs are acid-activated prodrugs: they pass through the stomach intact, get absorbed into the bloodstream, then return to the parietal cell canaliculi where acid converts them into a reactive form that binds the pump irreversibly. Because the bond is permanent, acid suppression lasts far longer than the drug's 1 to 2 hour plasma half-life. Roughly 70 to 80 percent of pumps must be blocked before acid output falls meaningfully, which is why PPIs take 2 to 4 days of daily dosing to reach full effect.
H2 blockers take a different route. Histamine, released by enterochromaffin-like cells, is one of three signals that drive acid secretion (the others being gastrin and acetylcholine). H2 receptor antagonists such as famotidine and cimetidine block the histamine signal only, so they suppress roughly 60 to 70 percent of meal-stimulated acid rather than the 90-plus percent seen with PPIs. They act within 60 minutes, which makes them useful for prevention when taken 15 to 60 minutes before a trigger meal.
Antacids do not suppress acid production at all. They neutralize acid already in the stomach through a direct acid-base reaction. Calcium carbonate raises gastric pH above 4 within about 5 minutes, but the effect fades within 30 to 60 minutes as the stomach empties and produces new acid. Alginate products add a mechanical layer: they form a floating raft on top of stomach contents that physically blocks refluxate from entering the esophagus, an effect that lasts roughly 4 hours.
In plain terms: antacids put out the fire, H2 blockers turn down the gas, and PPIs close the valve at the source.
The Comparison Table: Speed, Duration, and Cost Side by Side
The comparison below uses typical adult over-the-counter dosing and US retail pricing as of 2026; prescription-strength versions deliver 2 to 4 times the OTC dose of PPIs.
| Drug class | Example | Onset | Duration | Acid suppression | Typical OTC cost (30 days) | Best for |
|---|---|---|---|---|---|---|
| Antacid | Calcium carbonate 1,000 mg | 5 minutes | 30–60 minutes | Neutralizes existing acid only | USD 8–15 | Infrequent, predictable heartburn |
| Alginate-antacid | Alginate plus antacid | 5 minutes | About 4 hours | Raft barrier plus neutralization | USD 12–20 | Post-meal and positional reflux |
| H2 blocker | Famotidine 10–20 mg | 60 minutes | 6–10 hours | 60–70% of stimulated acid | USD 10–20 | Nighttime symptoms, meal prevention |
| PPI (OTC) | Omeprazole 20 mg | 2–4 days to full effect | 24 hours per dose | 90%+ of stimulated acid | USD 15–25 | Frequent symptoms, 2+ days per week |
| PPI (Rx) | Esomeprazole 40 mg | 2–4 days | 24 hours per dose | 90%+ of stimulated acid | Varies by insurance | Erosive esophagitis, Barrett's esophagus |
The cost column matters less than the duration column for most people. A person with heartburn twice a month spends about USD 10 a year on antacids; the same person switching to a daily PPI spends roughly USD 200, which the 2026 American Gastroenterological Association guidance does not support for that frequency.
The Timeline of Relief: What Happens in the First 8 Weeks
Acid reflux treatment follows a predictable time course, and knowing where you are on it prevents the most common error: judging a PPI as ineffective after 3 days.
| Time point | What happens | What to expect |
|---|---|---|
| 0–5 minutes | Antacid neutralizes gastric acid; alginate raft forms | Immediate burning relief, lasting under 1 hour for antacids |
| 15–60 minutes | H2 blocker reaches peak plasma level | Prevention of meal-triggered symptoms if taken before eating |
| Day 1–3 | PPI accumulates; pumps bind progressively | Partial relief; symptoms may still occur |
| Day 4–7 | PPI reaches steady-state 90%+ suppression | Substantial symptom reduction in most patients |
| Week 2 | Mucosal healing begins in mild esophagitis | Reduced regurgitation, less nocturnal cough |
| Week 4 | About 70–80% of mild esophagitis healed | If no improvement, reassess dosing timing first |
| Week 8 | 80–90% of erosive esophagitis healed per 2022 ACG guidelines | Persistent symptoms at this point need endoscopy evaluation |
| Month 6+ | Maintenance decision | Step down to lowest effective dose, or continue if Barrett's esophagus present |
The critical reconciliation: OTC labeling allows 14 days of PPI use and prescription courses run 4 to 8 weeks, but these are not contradictory. The 14-day OTC limit exists because undiagnosed persistent symptoms need a doctor, not because PPIs stop working after two weeks. A physician-supervised 8-week course is the standard for confirmed reflux disease.
Edge Cases That Change the Answer
Nighttime reflux flips the drug hierarchy. PPIs taken in the morning wear off by 2 to 3 a.m., when nocturnal acid breakthrough occurs in up to 70 percent of patients on twice-daily PPI therapy. For these patients, adding an H2 blocker at bedtime often beats increasing the PPI dose. However, tolerance to H2 blockers develops within 2 to 6 weeks of continuous use in a substantial minority of patients, so intermittent or on-demand bedtime dosing preserves their effect.
Reflux without heartburn, sometimes called silent reflux or laryngopharyngeal reflux, is often misjudged. It presents as hoarseness, throat clearing, or a chronic cough. The evidence for PPIs here is weaker than for classic heartburn: response rates run around 50 percent in trials, and the 2022 ACG guidelines advise an 8-week trial at most before stopping if there is no response.
Obesity, pregnancy, and older age each shift the calculus. Weight loss of 10 percent or more reduces reflux symptom frequency meaningfully, which is comparable in magnitude to drug therapy for some patients. In pregnancy, calcium carbonate antacids are first-line and H2 blockers are considered acceptable, while PPIs are reserved for refractory cases under obstetric guidance. In adults over 60, PPI interaction checks matter more: omeprazole reduces clopidogrel activation via CYP2C19, an interaction with clinical significance for patients on that antiplatelet drug.
Misconceptions That Lead People to the Wrong Medicine
The biggest misconception is that stronger equals better. The 2022 ACG guidelines recommend the lowest effective PPI dose and explicitly support on-demand or intermittent PPI use for patients without erosive disease. A person with twice-weekly heartburn does not need daily 40 mg esomeprazole.
A second misconception concerns PPI safety. Observational studies have linked long-term PPI use to fracture, kidney disease, and infection risks, but these are associations confounded by the conditions PPIs treat, and randomized trial data have not confirmed causation. The 2022 ACG position is that benefits outweigh these uncertain risks for patients with a clear indication. The corrected framing: the risk of untreated erosive esophagitis and Barrett's esophagus progression is established, while most proposed PPI harms are hypothesis-level.
A third misconception involves timing. Taken with breakfast, omeprazole's acid suppression is roughly 50 percent lower than when taken 30 to 60 minutes before the meal, because the drug needs active pumps to bind. Most people who think PPIs failed them actually took the pill at the wrong time or with food that delayed absorption.
What to Actually Do: A Stepwise Plan
Work through these steps in order rather than jumping to the strongest product.
- Track symptom frequency for two weeks. Count days with symptoms out of 14; this single number determines which drug class fits.
- For fewer than 2 symptom days per week, use calcium carbonate or an alginate product as needed, taken at symptom onset or 15 minutes before a trigger meal.
- For 2 or more days per week, start omeprazole 20 mg taken 30 to 60 minutes before breakfast for 14 days, and log whether days 4 through 14 improve.
- If nighttime symptoms persist, add famotidine 10 to 20 mg at bedtime, using it no more than 3 nights per week to limit tolerance.
- If symptoms persist after 8 weeks of correct PPI use, see a clinician for endoscopy evaluation rather than escalating to a second daily dose on your own.
- Address the mechanical contributors in parallel: elevate the head of the bed 6 to 8 inches, avoid meals within 3 hours of lying down, and target a 5 to 10 percent body weight reduction.
The positive-action principle: the most effective reflux regimen combines the right drug class at the right dose with one or two mechanical changes. Drug therapy alone leaves the positional and dietary triggers untouched, which is why about 30 percent of patients remain partially symptomatic on a PPI.
Red Flags and the Limits of Self-Treatment
Self-treatment with any reflux medicine has hard boundaries. The following symptoms are not heartburn management problems; they require medical evaluation, often urgent, because reflux medicines can mask serious disease.
- Difficulty or pain when swallowing, or food feeling stuck
- Unintentional weight loss alongside reflux symptoms
- Vomiting blood or passing black, tarry stools
- Chest pain radiating to the arm, jaw, or back, especially with sweating or shortness of breath
- Anemia discovered on routine blood work
- New reflux symptoms beginning after age 60
The limitations of the answer are real. No reflux medicine treats the underlying cause, which is usually a mechanically incompetent lower esophageal sphincter, and relapse after stopping a PPI occurs in 70 to 80 percent of patients with erosive disease within 6 months. PPIs also do not fully control weakly acidic reflux, which explains persistent symptoms in roughly 1 in 3 patients despite correct dosing. For those patients, the next step is not a stronger medicine but reflux monitoring and evaluation for procedural options such as fundoplication. The best medicine for acid reflux is therefore a matched decision, not a ranked list: antacids for the occasional fire, H2 blockers for the predictable night, and PPIs for the patient whose esophagus needs genuine healing over weeks.